News | June 11, 2026
Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
The Prayagraj lab is designed to handle both routine and specialised testing
The Prayagraj lab is designed to handle both routine and specialised testing
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
The award places the company in the top 5% globally
Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
